Jaye Thompson
CIK 1476971 · VP Clinical Reg Affairs · last filed 2024-12-27
Jaye Thompson is a VP Clinical Reg Affairs who has filed 34 SEC Form 4 insider transactions across 5 companies since 2009. The most recent filing, for GLSI, was dated Dec 27, 2024. Across all open-market trades the lifetime net is +$164.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $6.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.36M
5
34
$164.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GLSI | VP Clinical Reg Affairs | 264,148 | $24.06 | $6.36M | $164.8K | 23 | 2024-12-27 |
| RPRX | See Remarks | — | $54.87 | — | $0 | 1 | 2016-07-06 |
| REPROS THERAPEUTICS INC. (RPRX.Z) Delisted | Senior Vice President | — | — | — | $0 | 1 | 2013-03-28 |
| Acer Therapeutics Inc. (OPXAW) Delisted | SVP Clinical Dev & Reg Affairs | — | — | — | $0 | 4 | 2013-01-25 |
| REPROS THERAPEUTICS INC. (RPRXZ) Delisted | Director | — | — | — | $0 | 3 | 2012-06-14 |
Recent Filings
34 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-12-27 | GLSI | Grant (A) | — | $0 | EDGAR |
| 2024-11-25 | GLSI | Buy (P) | +1,000 | $12.9K | EDGAR |
| 2024-09-16 | GLSI | Buy (P) | +800 | $11.1K | EDGAR |
| 2024-08-05 | GLSI | Buy (P) | +1,000 | $15.2K | EDGAR |
| 2024-07-22 | GLSI | Buy (P) | +1,000 | $16.0K | EDGAR |
| 2023-10-31 | GLSI | Buy (P) | +500 | $4.3K | EDGAR |
| 2023-09-28 | GLSI | Buy (P) | +600 | $5.2K | EDGAR |
| 2023-07-17 | GLSI | Buy (P) | +250 | $2.4K | EDGAR |
| 2023-05-02 | GLSI | Buy (P) | +250 | $2.8K | EDGAR |
| 2023-04-12 | GLSI | Buy (P) | +1,000 | $11.9K | EDGAR |